Search Ontology:
ChEBI
alpha-N-acetylneuraminyl-(2->3)-beta-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->3)-6-deoxy-alpha-L-galactopyranosyl group
- Term ID
- CHEBI:62691
- Synonyms
-
- 5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranonosyl-(2->3)-beta-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->3)-6-deoxy-alpha-L-galactopyranosyl
- Neu5Ac(alpha2,3)Gal(beta1,4)GlcNAc(beta1,3)Fuc(alpha1)
- Neu5Acalpha2-3Galbeta1-4GlcNAcbeta1-3Fucalpha-
- Definition
- A fucosyl group in which a sialic acid residue (Neu5Ac) is linked alpha(2->3) to a beta-D-Gal-(1->4)-D-GlcNAc unit which is itself linked beta(1->3) to an L-fucose group which has alpha-configuration at its anomeric centre.
- References
- Ontology
- ChEBI ( EBI )
- is a type of
-
Phenotype
Phenotype resulting from alpha-N-acetylneuraminyl-(2->3)-beta-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->3)-6-deoxy-alpha-L-galactopyranosyl group
Phenotype where environments contain alpha-N-acetylneuraminyl-(2->3)-beta-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->3)-6-deoxy-alpha-L-galactopyranosyl group
Phenotype modified by environments containing alpha-N-acetylneuraminyl-(2->3)-beta-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->3)-6-deoxy-alpha-L-galactopyranosyl group
Human Disease Model